| Multivariate analysis | Diagnostic ability of clinical signs | |||||
---|---|---|---|---|---|---|---|
Variables | Hazard ratio | 95% CI | p-value | Sensitivity | Specificity | PPV | NPV |
Patient conditions | |||||||
Immunosuppr. therapy1 | 1.07 | 0.80–1.43 | 0.63 | – | – | – | – |
Malignancy2 | 1.08 | 0.67–1.75 | 0.75 | – | – | – | – |
Dementia | 1.62 | 0.18–14.58 | 0.67 | – | – | – | – |
Clinical signs | Â | Â | Â | Â | Â | Â | Â |
Local signs | Â | Â | Â | Â | Â | Â | Â |
Pain | 0.55 | 0.17–1.81 | 0.33 | 9.6% | 98.7% | 38.8% | 92.5% |
Rash | 2.82 | 0.82–9.69 | 0.10 | 8.2% | 99.6% | 66.7% | 92.5% |
Systemic signs | |||||||
Fever | 13.21 | 6.00–29.11 |  < 0.001 | 83.6% | 93.0% | 51.3% | 98.5% |
Chills | 3.66 | 1.92–6.99 |  < 0.001 | 64.4% | 97.2% | 67.1% | 96.9% |
Dyspnoea | 1.24 | 0.53–2.94 | 0.62 | 12.0% | 99.4% | 64.3% | 93.0% |
PICC duration ≥ 28 days | – | – | – | 53.4% | 62.8% | 11.2% | 93.9% |